In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity

Haile, Lydia A.; Puig, Montserrat; Polumuri, Swamy K.; Ascher, Jill; Verthelyi, Daniela

doi:10.1016/j.xphs.2016.11.001

Title: In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity

Full Record
Other Related Research

Authors:: Haile, Lydia A.; Puig, Montserrat; Polumuri, Swamy K.; Ascher, Jill; Verthelyi, Daniela

Publication Date:: Wed Mar 01 00:00:00 EST 2017

Sponsoring Org.:: USDOE

OSTI Identifier:: 1411817

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Journal of Pharmaceutical Sciences

Additional Journal Information:: Journal Name: Journal of Pharmaceutical Sciences Journal Volume: 106 Journal Issue: 3; Journal ID: ISSN 0022-3549

Publisher:: Elsevier

Country of Publication:: United States

Language:: English

Citation Formats


                    Haile, Lydia A., Puig, Montserrat, Polumuri, Swamy K., Ascher, Jill, and Verthelyi, Daniela. In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity.  United States: N. p., 2017. 
Web.  doi:10.1016/j.xphs.2016.11.001.

Copy to clipboard


                    Haile, Lydia A., Puig, Montserrat, Polumuri, Swamy K., Ascher, Jill, & Verthelyi, Daniela. In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity.  United States.  https://doi.org/10.1016/j.xphs.2016.11.001

Copy to clipboard


                    Haile, Lydia A., Puig, Montserrat, Polumuri, Swamy K., Ascher, Jill, and Verthelyi, Daniela. Wed .  
"In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity".  United States.  https://doi.org/10.1016/j.xphs.2016.11.001.

Copy to clipboard


                    
@article{osti_1411817,

  title        = {In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity},

  author       = {Haile, Lydia A. and Puig, Montserrat and Polumuri, Swamy K. and Ascher, Jill and Verthelyi, Daniela},

  abstractNote = {},

  doi          = {10.1016/j.xphs.2016.11.001},

  journal      = {Journal of Pharmaceutical Sciences},

  number       = 3,

  volume       = 106,

  place        = {United States},

  year         = {Wed Mar 01 00:00:00 EST 2017},

  month        = {Wed Mar 01 00:00:00 EST 2017}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.xphs.2016.11.001

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 13 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients

Journal Article Thacker, Seth G. ; Her, Cheng ; Kelley-Baker, Logan ; ... - Frontiers in Immunology

Unintended immunogenicity can affect the safety and efficacy of therapeutic proteins and peptides, so accurate assessments of immunogenicity risk can aid in the selection, development, and regulation of biologics. Product- and process- related impurities can act as adjuvants that activate the local or systemic innate immune response increasing the likelihood of product immunogenicity. Thus, assessing whether products have innate immune response modulating impurities (IIRMI) is a key component of immunogenicity risk assessments. Identifying trace levels of individual IIRMI can be difficult and testing individually for all potential impurities is not feasible. Therefore, to mitigate the risk, cell-based assays that usemore »« less
https://doi.org/10.3389/fimmu.2022.970499

Full Text Available
Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities

Journal Article Polumuri, Swamy Kumar ; Haile, Lydia A. ; Ireland, Derek D. C. ; ... - Scientific Reports

Therapeutic proteins can induce immune responses that affect their safety and effcacy. Product aggregates and innate immune response modulating impurities (IIRMI) are risk factors of product immunogenicity. In this study, we use Intravenous Immunoglobulin (IVIG), Avastin, and Human Serum Albumin (HSA) to explore whether increased aggregates activate innate immune cells or modify the response to IIRMI. We show that increased aggregates (shaken or stirred) in IVIG and Avastin, but not HSA, induced activation of MAPKs (pp38, pERK and pJNK) and transcription of immune-related genes including IL8, IL6, IL1β, CSF1, CCL2, CCL7, CCL3, CCL24, CXCL2, IRAK1, EGR2, CEBPβ, PPARg and TNFSF15more »« less
https://doi.org/10.1038/s41598-018-29850-4

Full Text Available
Analysis of protective and cytotoxic immune responses in vivo against metabolically inactivated and untreated cells of a mutagenized tumor line (requirements for tumor immunogenicity)

Journal Article Wehrmaker, A ; Lehmann, V ; Droege, W - Cell. Immunol.; (United States)

The immunogenicity of a mutagenized subline (ESb-D) of the weakly immunogenic T-cell lymphoma L 5178 Y ESb has been characterized. The injection of 10(6) ESb-D cells ip did not establish lethal tumors in untreated DBA/2 mice but established tumors in sublethally irradiated mice. Injection of ESb-D cells into otherwise untreated DBA/2 mice established also a state of protective immunity against the subsequent injection of otherwise lethal doses of ESb tumor cells. Protection was only obtained after injection of intact but not UV-irradiated or mitomycin-C-treated ESb-D cells. A direct T-cell-mediated cytotoxic activity was also demonstrable in the spleen cells of DBA/2more »« less
https://doi.org/10.1016/0008-8749(86)90142-5
Effects of in Vivo Cd8⁺ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine

Journal Article Metzner, Karin J. ; Jin, Xia ; Lee, Fred V. ; ... - Journal of Experimental Medicine

The role of CD8⁺ T lymphocytes in controlling replication of live, attenuated simian immunodeficiency virus (SIV) was investigated as part of a vaccine study to examine the correlates of protection in the SIV/rhesus macaque model. Rhesus macaques immunized for > 2 yr with nef-deleted SIV (SIVmac239Δnef) and protected from challenge with pathogenic SIVmac251 were treated with anti-CD8 antibody (OKT8F) to deplete CD8⁺ T cells in vivo. The effects of CD8 depletion on viral load were measured using a novel quantitative assay based on real-time polymerase chain reaction using molecular beacons. This assay allows simultaneous detection of both the vaccine strainmore »« less
https://doi.org/10.1084/jem.191.11.1921

Full Text Available
Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Journal Article Imai, Hirotaka ; Dansako, Hiromichi ; Ueda, Youki ; ... - Biochemical and Biophysical Research Communications

Hepatitis B virus (HBV) causes hepatic diseases such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. These diseases are closely associated with persistent HBV infection. To prevent the progression of hepatic diseases, it is thus important to suppress persistent HBV infection. Daunorubicin (DNR), a topoisomerase II (Top II) poison, is a clinically used anticancer agent with a wide spectrum of activity against malignancies. DNR was recently reported to cause DNA damage-dependent interferon (IFN)-β induction through exogenous cyclic GMP-AMP synthetase (cGAS) and subsequently to suppress Ebola virus replication. In the present study, we demonstrated that DNR caused the inhibition of cellmore »« less
https://doi.org/10.1016/J.BBRC.2018.08.195

Similar Records